<DOC>
	<DOCNO>NCT01015235</DOCNO>
	<brief_summary>The purpose study determine whether KAI-1678 effective treatment postoperative pain follow total hip total knee replacement .</brief_summary>
	<brief_title>Safety Efficacy Study KAI-1678 Treat Subjects With Postoperative Pain</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>American Society Anesthesiologist ( ASA ) classification 1 , 2 , 3 total hip total knee replacement pain postoperative Day 1 least 40 mm 0100 mm visual analog scale ( VAS ) presence contraindication nonsteroidal antiinflammatory ( NSAID ) treatment recent history angina myocardial infarction ( MI ) clinically significant abnormality laboratory test electrocardiogram ( ECG )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Ketorolac / therapeutic use</keyword>
	<keyword>Analgesics . Non-narcotic / therapeutic use</keyword>
	<keyword>Arthroplasty , replacement hip</keyword>
	<keyword>Arthroplasty , replacement knee</keyword>
	<keyword>Pain measurement / drug effect</keyword>
	<keyword>Pain postoperative / drug therapy</keyword>
</DOC>